Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC GNE-886 | 2101957-05-3 | 99.8% | 498.58 | C28H30N6O3 | 50 MG
SDP

Catalog No. 5000226546
Encompass_Preferred

GNE-886 is a potent, selective small-molecule inhibitor of the CECR2 bromodomain used for epigenetic reader-domain research and cellular assays. Supplied as a 50 mg research sample with reported purity 99.81%, it has molecular formula C28H30N6O3 and molecular weight 498.58; reported potency is IC50 = 0.016 μM (CECR2) and EC50 = 370 nM in cellular assays.

  • Potent and selective CECR2 bromodomain inhibition.
  • High purity (99.81%) suitable for biochemical and cellular studies.
  • Small-scale package for research use and lead optimization.
  • Well-characterized by molecular formula and molecular weight.
  • Datasheet and certificate of analysis available.

Catalog No. 50-002-26546 Supplier Medchemexpress LLC Supplier No. HY11786550MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

GNE-886 is a potent, selective small-molecule inhibitor of the CECR2 bromodomain used for epigenetic reader-domain research and cellular assays. Supplied as a 50 mg research sample with reported purity 99.81%, it has molecular formula C28H30N6O3 and molecular weight 498.58; reported potency is IC50 = 0.016 μM (CECR2) and EC50 = 370 nM in cellular assays.

  • Potent and selective CECR2 bromodomain inhibition.
  • High purity (99.81%) suitable for biochemical and cellular studies.
  • Small-scale package for research use and lead optimization.
  • Well-characterized by molecular formula and molecular weight.
  • Datasheet and certificate of analysis available.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.